(Q41377973)

30 September 2017

1 reference

title

Practical modalities for prevention of fungal infections in cancer patients (English)

1 reference

30 September 2017

De Pauw BE

1

1 reference

30 September 2017

publication date

1 January 1997

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

30 September 2017

published in

1 reference

30 September 2017

volume

16

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

32-41

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01575119

30 September 2017

exact match

0 references

cites work

Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01575119

Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study

21 January 2018

1 reference

12 December 2020

Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias

1 reference

12 December 2020

Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group

1 reference

12 December 2020

Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.

1 reference

12 December 2020

Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.

1 reference

12 December 2020

Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome

1 reference

12 December 2020

Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases

1 reference

12 December 2020

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

1 reference

12 December 2020

Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy

1 reference

12 December 2020

Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B

1 reference

12 December 2020

Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

1 reference

12 December 2020

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

1 reference

12 December 2020

Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.

1 reference

12 December 2020

A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia

1 reference

12 December 2020

Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients

1 reference

12 December 2020

Candida and Aspergillus Infections in Immunocompromised Patients: An Overview

1 reference

12 December 2020

Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients

1 reference

12 December 2020

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

12 December 2020

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

1 reference

12 December 2020

Candida colonization and systemic infection in neutropenic patients. A retrospective study

1 reference

12 December 2020

New methods for delivery of antifungal agents

1 reference

12 December 2020

A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group

1 reference

12 December 2020

Fungal infections in cancer patients: an international autopsy survey.

1 reference

12 December 2020

An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis

1 reference

12 December 2020

Prophylaxis of fungal infections with itraconazole during remission-induction therapy

1 reference

12 December 2020

Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients

1 reference

12 December 2020

Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients

1 reference

12 December 2020

Treatment of invasive aspergillosis with itraconazole

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

The value of fungal surveillance cultures as predictors of systemic fungal infections

1 reference

12 December 2020

Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels

1 reference

12 December 2020

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

12 December 2020

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

12 December 2020

Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. Working party of the British Society for Antimicrobial Chemotherapy

1 reference

12 December 2020

Itraconazole in leukemic patients with invasive aspergillosis (IA): impact on intensive chemotherapy completion

1 reference

12 December 2020

The prophylactic use of low-dose amphotericin B in bone marrow transplant patients

1 reference

12 December 2020

The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B

1 reference

12 December 2020

Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients

1 reference

12 December 2020

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

1 reference

12 December 2020

Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients

1 reference

12 December 2020

Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism

1 reference

12 December 2020

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

12 December 2020

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

1 reference

12 December 2020

Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01575119

1 reference

Dimensions Publication ID

30 September 2017

1029523324

0 references

1 reference